Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|MEN: MENINGOCOCCAL (NO BRAND NAME) / UNKNOWN MANUFACTURER||VNS1S12D / UNK||- / -|
|PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH||W19703 / UNK||- / -|
Administered by: Other Purchased by: ??
Symptoms: Death, Autopsy
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Preexisting Conditions: Comments: None
Diagnostic Lab Data:
CDC 'Split Type': ESPFIZER INC2019354059
Write-up: death; This is a spontaneous report from a contactable Other Health Professional from the local Regulatory Authority (Regulatory Authority ES-AEMPS-533524). A 4-month-old male patient received meningococcal group C tetanus toxoid conjugate vaccine (NEISVAC-C, lot#: VNS1S12D) and pneumococcal 13-valent conjugated vaccine (dipht crm197 protein) (PREVENAR 13, lot#: W19703), both via an unspecified route of administration on an unspecified date at single dose for vaccination, and diphtheria vaccine toxoid, hepatitis b vaccine rhbsag (yeast), hib vaccine conj, pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero), tetanus vaccine toxoid (INFANRIX HEXA, lot#: A21CD077A), via an unspecified route of administration on an unspecified date at unspecified dose for vaccination. The patient had no relevant medical history. The patient''s concomitant medications were not reported. The patient experienced death on an unspecified date the night after vaccination. An autopsy was performed and results were not provided.; Reported Cause(s) of Death: death
Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166